{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Vertex Pharmaceuticals Incorporated"},"Symbol":{"label":"Symbol","value":"VRTX"},"Address":{"label":"Address","value":"50 NORTHERN AVENUE, BOSTON, Massachusetts, 02210, United States"},"Phone":{"label":"Phone","value":"+1 617 341-6100"},"Industry":{"label":"Industry","value":"Biotechnology: Pharmaceutical Preparations"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs are Kalydeco, Orkambi, Symdeko, and Trikafta/Kaftrio for cystic fibrosis, where Vertex therapies remain the standard of care globally. In addition to its focus on cystic fibrosis, Vertex is diversifying its pipeline through gene-editing therapies such as CTX001 for beta-thalassemia and sickle-cell disease, small-molecule inhibitors targeting acute and chronic pain using non-opioid treatments, and small-molecule inhibitors of APOL1-mediated kidney diseases. Vertex is also investigating cell therapies to deliver a potential functional cure for type 1 diabetes."},"CompanyUrl":{"label":"Company Url","value":"https://www.vrtx.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Carmen Bozic","title":"Chief Medical Officer & EVP-Medical Affairs"},{"name":"David Matthew Altshuler","title":"Chief Scientific Officer & EVP-Global Research"},{"name":"Edward Morrow Atkinson","title":"Chief Technical Operations Officer & Executive VP"},{"name":"Mark Bunnage","title":"Senior Vice President & Head-Research"},{"name":"Mike Tirozzi","title":"Senior VP, Chief Information & Data Officer"},{"name":"Reshma Kewalramani","title":"President, Chief Executive Officer & Director"},{"name":"Sean Daughtry","title":"Senior Director-Analytical Sciences & Technology"},{"name":"Stuart A. Arbuckle","title":"Chief Operating Officer & Executive Vice President"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}